BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 10228148)

  • 1. Conformation of the Bax C-terminus regulates subcellular location and cell death.
    Nechushtan A; Smith CL; Hsu YT; Youle RJ
    EMBO J; 1999 May; 18(9):2330-41. PubMed ID: 10228148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the role of the C-terminus of Bax and of tc-Bid on Bax interaction with yeast mitochondria.
    Priault M; Cartron PF; Camougrand N; Antonsson B; Vallette FM; Manon S
    Cell Death Differ; 2003 Sep; 10(9):1068-77. PubMed ID: 12934081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-terminus of bax is not a membrane addressing/anchoring signal.
    Tremblais K; Oliver L; Juin P; Le Cabellec TM; Meflah K; Vallette FM
    Biochem Biophys Res Commun; 1999 Jul; 260(3):582-91. PubMed ID: 10403809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC.
    Shimizu S; Narita M; Tsujimoto Y
    Nature; 1999 Jun; 399(6735):483-7. PubMed ID: 10365962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
    Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells.
    Murphy KM; Ranganathan V; Farnsworth ML; Kavallaris M; Lock RB
    Cell Death Differ; 2000 Jan; 7(1):102-11. PubMed ID: 10713725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational control of Bax localization and apoptotic activity by Pro168.
    Schinzel A; Kaufmann T; Schuler M; Martinalbo J; Grubb D; Borner C
    J Cell Biol; 2004 Mar; 164(7):1021-32. PubMed ID: 15037603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
    Murphy KM; Streips UN; Lock RB
    Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2.
    Nomura M; Shimizu S; Ito T; Narita M; Matsuda H; Tsujimoto Y
    Cancer Res; 1999 Nov; 59(21):5542-8. PubMed ID: 10554032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
    Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
    EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanin peptide suppresses apoptosis by interfering with Bax activation.
    Guo B; Zhai D; Cabezas E; Welsh K; Nouraini S; Satterthwait AC; Reed JC
    Nature; 2003 May; 423(6938):456-61. PubMed ID: 12732850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.
    Sawada M; Hayes P; Matsuyama S
    Nat Cell Biol; 2003 Apr; 5(4):352-7. PubMed ID: 12652309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
    Zhou H; Hou Q; Chai Y; Hsu YT
    Exp Cell Res; 2005 Oct; 309(2):316-28. PubMed ID: 16061221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
    Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR
    Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator.
    Shimizu S; Shinohara Y; Tsujimoto Y
    Oncogene; 2000 Sep; 19(38):4309-18. PubMed ID: 10980606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L; Yuan J; Stein R
    Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria.
    Soucie EL; Annis MG; Sedivy J; Filmus J; Leber B; Andrews DW; Penn LZ
    Mol Cell Biol; 2001 Jul; 21(14):4725-36. PubMed ID: 11416148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
    Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
    BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of the oligomeric state of Bax and its complex formation with Bcl-XL.
    Tan YJ; Beerheide W; Ting AE
    Biochem Biophys Res Commun; 1999 Feb; 255(2):334-9. PubMed ID: 10049709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.